Raymond James Financial’s AbbVie ABBV Stock Holding History

Raymond James Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.09B	Buy	9,604,349 +206,615	+2%	+$45.8M	0.64%	20
2025 Q4	$2.15B	Sell	9,397,734 -159,967	-2%	-$36.4M	0.67%	19
2025 Q3	$2.21B	Buy	9,557,701 +220,221	+2%	+$44.8M	0.71%	18
2025 Q2	$1.73B	Buy	9,337,480 +2,753,312	+42%	+$512M	0.6%	22
2025 Q1	$1.38B	Sell	6,584,168 -117,866	-2%	-$22.9M	0.52%	27
2024 Q4	$1.19B	Buy	+6,702,034	New	+$1.23B	0.44%	32

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Raymond James Financial's ABBV Position: Q1 2026 in Review

Raymond James Financial increased its AbbVie (ABBV) stake by 2.2% in Q1 2026, buying an estimated $45.8M and bringing the position to 9,604,349 shares worth $2.09B. The position accounts for 0.64% of the portfolio, ranked #20.

Raymond James Financial first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.21B in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Raymond James Financial held 9,604,349 shares of AbbVie worth $2.09B as of Q1 2026.
Raymond James Financial bought 206,615 AbbVie shares in Q1 2026, an estimated $45.8M.
AbbVie made up 0.64% of Raymond James Financial's portfolio in Q1 2026, its #20 holding.
Raymond James Financial first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's AbbVie position peaked at $2.21B in Q3 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.